论文部分内容阅读
心力衰竭(心衰)为高发终末期慢性病,且并发症、死亡风险、再住院风险和治疗花费均高,降低生活质量。目前有效治疗手段有限,迄今关于评估其近期再住院风险的相关预测指标相对罕见,现就血浆半乳糖凝素-3水平升高与心衰近期再住院风险间关系进行分析。受试对象为3项试验中的902例心衰患者,基线年龄61.2~72.9岁,男性53.6%~72.1%。研究中均采血测定各自基线血中半乳糖凝素-3、利钠肽、血肌酐等水平。同时测定各自左室射血分数(LVEF)。人均随访约120 d,在校正诸混杂影
Heart failure (heart failure) is a high incidence of end-stage chronic disease, and the complications, the risk of death, the risk of rehospitalization and the cost of treatment are both high and the quality of life is reduced. Currently, there are limited effective treatments. So far, the relevant predictors for assessing their recent rehospitalization risk are relatively infrequent. The relationship between the elevated plasma levels of Galectin-3 and the recent rehospitalization of heart failure is analyzed. The subjects were 902 heart failure patients in three trials, with a mean age of 61.2 to 72.9 years and 53.6 to 72.1% of men. In the study, blood samples were collected to determine the levels of galectin-3, natriuretic peptide and serum creatinine in baseline blood respectively. Left ventricular ejection fraction (LVEF) was measured at the same time. Per capita follow-up of about 120 d, in the correction of all mixed shadow